SAJA Pharmaceutical opens its New office in Dubai.
“We are interested in medicine, developmental research, and artificial intelligence. Among the plans , the opening of a unit specialized in cancer diseases” Mohamad Taher
Dubai, United Arab Emirates:
SAJA Pharmaceutical Company, the Saudi-Japanese Pharmaceutical Company, one of the TAMAR Holding Group companies, opened its new office in Dubai Healthcare City, as part of its goal to expand its presence in the Middle East region, which constitutes a qualitative shift in Emirati cooperation with Saudi Arabia in the health field, especially pharmaceutical manufacturing and therapeutical security.
The opening attracted the participation of prominent figures in the field of healthcare, most notably His Excellency Dr. Ali Al Sayed, Director of the Pharmacy Department at the Dubai Health Authority and Chairman of the “DUPHAT” Conference and Exhibition, Dr. Mohamed Taher, Chairman of the Board of Directors of SAJA Company and CEO of Tamer Holding Group, and Dr. Mohamed Khalil, President Executive Director of SAJA Pharmaceutical Company, and Dr. Mahmood Ghaly, General Manager of SAJA Company in the Gulf region, The opening also witnessed a distinguished presence of a group of prominent figures in the field of health care and CEOs of major pharmaceutical import and distribution companies in the Gulf region.
UAE News 24/7 